Skip to main content

TactiFlex PAF IDE - Safety and Effectiveness of TactiFlex Ablation Catheter, Sensor Enabled TactiFlex SE for the Treatment of Drug Refractory, Symptomatic, Paroxysmal Atrial Fibrillation

NCT04356040

TactiFlex PAF IDE - Safety and Effectiveness of TactiFlex Ablation Catheter, Sensor Enabled TactiFlex SE for the Treatment of Drug Refractory, Symptomatic, Paroxysmal Atrial Fibrillation

Associated Conditions

Atrial Fibrillation

Principal Investigator

Sponsor

Abbott

The purpose of this research study is to demonstrate that the TactiFlex SE catheter is safe and effective for ablating your symptomatic, paroxysmal atrial fibrillation that is not effectively treated with medication. Data collected for this study will be submitted for review and approval by the FDA and may be submitted to regulatory agencies in other geographies such as the European Union, Australia and/or Canada.

This study is currently enrolling.